Clinical Trial Update: Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies [Phase 3]

View source ↗

Summary

Phase 3 trial update on systemic treatments for bone metastases in metastatic renal cell carcinoma patients treated with targeted therapies; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Centre Leon Berard | Conditions: Metastatic Renal Cell Carcinoma | Phase 3 | Status: TERMINATED